HK1211212A1 - 抗癡呆症劑及學習記憶改善劑 - Google Patents

抗癡呆症劑及學習記憶改善劑

Info

Publication number
HK1211212A1
HK1211212A1 HK15112039.1A HK15112039A HK1211212A1 HK 1211212 A1 HK1211212 A1 HK 1211212A1 HK 15112039 A HK15112039 A HK 15112039A HK 1211212 A1 HK1211212 A1 HK 1211212A1
Authority
HK
Hong Kong
Prior art keywords
antidementia
learning
memory function
improving drug
drug
Prior art date
Application number
HK15112039.1A
Other languages
English (en)
Inventor
Nobuo Tsuruoka
Hiroshi Watanabe
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of HK1211212A1 publication Critical patent/HK1211212A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15112039.1A 2012-11-21 2015-12-07 抗癡呆症劑及學習記憶改善劑 HK1211212A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012255047A JP6291158B2 (ja) 2012-11-21 2012-11-21 抗認知症および学習記憶改善剤
PCT/JP2013/081371 WO2014080973A1 (ja) 2012-11-21 2013-11-21 抗認知症および学習記憶改善剤

Publications (1)

Publication Number Publication Date
HK1211212A1 true HK1211212A1 (zh) 2016-05-20

Family

ID=50776151

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112039.1A HK1211212A1 (zh) 2012-11-21 2015-12-07 抗癡呆症劑及學習記憶改善劑

Country Status (13)

Country Link
US (1) US9877960B2 (zh)
JP (1) JP6291158B2 (zh)
KR (1) KR102142168B1 (zh)
CN (1) CN104936597B (zh)
AU (1) AU2013348836B2 (zh)
GB (1) GB2523044B (zh)
HK (1) HK1211212A1 (zh)
MY (1) MY183914A (zh)
NZ (1) NZ708648A (zh)
PH (1) PH12015501115A1 (zh)
SG (2) SG11201503967QA (zh)
TW (1) TWI620564B (zh)
WO (1) WO2014080973A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106716129B (zh) * 2014-09-26 2019-04-19 福满代谢组技术有限公司 对抑郁症治疗药物的选项进行预测的方法
TW201709924A (zh) * 2015-07-16 2017-03-16 Suntory Holdings Ltd 含有來自動植物之胜肽的血清肌肽分解酵素阻礙用組成物
JPWO2017119481A1 (ja) * 2016-01-08 2018-11-08 サントリーホールディングス株式会社 環状ジペプチド含有神経性疾患予防用組成物
ES2960082T3 (es) 2016-05-31 2024-02-29 Morinaga Milk Industry Co Ltd Agente de mejora de función cerebral
US11162128B1 (en) * 2017-05-23 2021-11-02 The United States Of America As Represented By The Secretary Of The Army Mass spectrometry ionization based-assay for the detection of enzyme activity and/or presence
KR20230121869A (ko) * 2020-12-18 2023-08-21 산토리 홀딩스 가부시키가이샤 인지 기능의 저하를 억제시키거나 인지 기능 장애를개선시키기 위한 제제의 제조에서의 사이클릭 디펩타이드의 용도
CN113940286A (zh) * 2021-09-30 2022-01-18 南通大学 一种训练提升小鼠空间学习能力的方法
WO2023120407A1 (ja) * 2021-12-23 2023-06-29 サントリーホールディングス株式会社 アミロイドβの産生抑制及び/又は蓄積抑制用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3830096A1 (de) 1988-09-03 1990-03-15 Hoechst Ag Piperazindione mit psychotroper wirkung
JP4215857B2 (ja) 1998-03-26 2009-01-28 裕 大村 学習・記憶能力改善剤
JP2003221337A (ja) * 2002-01-29 2003-08-05 Dainippon Pharmaceut Co Ltd 酢酸アミド誘導体を有効成分とする痴呆症治療剤
PT1511710E (pt) * 2002-05-31 2014-02-26 Proteotech Inc Compostos, composições e métodos para o tratamento de doenças da amiloide e sinucleínopatias tais como doença de alzheimer, diabetes do tipo 2, e doença de parkinson
JP2008255087A (ja) 2007-03-13 2008-10-23 Kyowa Hakko Kogyo Co Ltd 自発運動促進剤
JP5058379B2 (ja) * 2009-12-25 2012-10-24 サントリーホールディングス株式会社 学習意欲改善剤
JP4901950B2 (ja) * 2009-12-25 2012-03-21 サントリーホールディングス株式会社 2,5−ピペラジンジオン,3,6−ビス(フェニルメチル)−,(3s,6s)−を含有する酸性飲食品
US20120283270A1 (en) * 2009-12-25 2012-11-08 Cerebos Pacific Limited Extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-, (3s,6s)-
JP2011213700A (ja) * 2010-04-02 2011-10-27 Nishizaki Soyaku Kenkyusho:Kk 認知症改善用組成物
JP2012246224A (ja) * 2011-05-25 2012-12-13 Suntory Holdings Ltd 抗認知症および学習記憶改善剤

Also Published As

Publication number Publication date
JP6291158B2 (ja) 2018-03-14
CN104936597A (zh) 2015-09-23
US20150297584A1 (en) 2015-10-22
GB2523044B (en) 2019-03-27
SG10201909517WA (en) 2019-11-28
SG11201503967QA (en) 2015-06-29
TW201436794A (zh) 2014-10-01
WO2014080973A1 (ja) 2014-05-30
AU2013348836B2 (en) 2018-08-16
GB201509976D0 (en) 2015-07-22
MY183914A (en) 2021-03-17
PH12015501115B1 (en) 2015-08-10
NZ708648A (en) 2019-08-30
CN104936597B (zh) 2019-01-11
KR20150086357A (ko) 2015-07-27
GB2523044A (en) 2015-08-12
AU2013348836A1 (en) 2015-07-02
JP2014101324A (ja) 2014-06-05
US9877960B2 (en) 2018-01-30
KR102142168B1 (ko) 2020-08-06
TWI620564B (zh) 2018-04-11
PH12015501115A1 (en) 2015-08-10

Similar Documents

Publication Publication Date Title
IL274988A (en) Carbamoylpyridone-polycyclic compounds and their pharmaceutical use
IL252566B (en) Pharmacy preparations and methods
IL234628A0 (en) Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs
HK1205334A1 (zh) 知覺-認知-運動學習系統和方法
EP2700436A4 (en) GAME SYSTEM AND GAME CONTROL UNIT
HK1204254A1 (zh) 單通路逆流導管裝置和方法
HK1211212A1 (zh) 抗癡呆症劑及學習記憶改善劑
HK1207046A1 (zh) 蓋子及蓋子部構造
EP2827300A4 (en) ZONE DESIGNATION METHOD AND DEVICE
EP2858006A4 (en) MEMORY DEVICE AND MEMORY SYSTEM
EP2875014A4 (en) ANTI-MUCUS MEDICAMENTS AND USES THEREOF
HK1198833A1 (zh) -酰基肽衍生物及其應用
GB2504390B (en) Nutraceutical and pharmaceutical composition
HK1203955A1 (zh) 反式- -癸烯酸衍生物及含有其的藥物
EP2817004A4 (en) BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES
GB201208315D0 (en) Pharmaceutical methods and compositions
GB201222541D0 (en) Kiddibidet and pottibidet
GB201219831D0 (en) Picture pinboard and noticeboard
IL218974A0 (en) Conaction bitwen coutch and playels
GB201202021D0 (en) Co-sleeper and breastfeeder